Natco to launch generic of Risdiplam for SMA patients
The company said it will launch the product immediately, with MRP of ₹15,900
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
spinal muscular atrophy
Evrysdi from ROCHE gets EC nod as home treatment for spinal muscular atrophy
The approval is based on data from two clinical studies, designed to represent a broad spectrum of people living with SMA:…
Roche gets US FDA approval for Evrysdi to treat spinal muscular atrophy
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of…
Roche’s SMA drug trial win bolsters $2 billion sales prospects
US regulators are due to decide by May 24